Thursday 24 July 2014

Keryx drug improves phosphorus, iron in kidney patients: trial

(Reuters) - A pivotal trial of Keryx Biopharmaceuticals Inc's experimental drug Zerenex showed that it improved levels of serum phosphorus and iron in patients on kidney dialysis, according to results published on Thursday. The trial involved 441 patients, according to the Journal of the American Society of Nephrology, which published the results. Over the four-week efficacy assessment period, mean serum phosphorus for Zerenex patients dropped by 2.2 milligrams per deciliter compared with placebo patients, the trial showed. Most patients with kidney disease that requires dialysis need chronic treatment with phosphate-binding agents to lower and maintain serum phosphorus at acceptable levels. via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment